The MPD Foundation funds innovative, accountable research that produces results for patients with polycythemia vera, essential thrombocythemia and myelofibrosis. Founded by patients, for patients, we have strong relationships with top researchers, clinicians and biopharmaceutical companies to ensure progress is being made to get us closer to a cure. The MPD Foundation supports innovative efforts to advance scientific understanding of the causes and potential treatments for polycythemia vera, primary myelofibrosis and essential thrombocythemia. To date, the Foundation has awarded over seven million dollars for MPD research. The Foundation’s esteemed Scientific Advisory Board utilizes a rigorous selection process to ensure donations are allocated to the most innovative research projects. The scientific advisory board includes highly regarded physicians from Scripps, University of Utah, BC Cancer Research Center and Weill Cornell.